Stockreport

CytoMed makes cash bid for potential acquisition of TC BioPharm Limited’s relevant assets

CytoMed Therapeutics Limited - Ordinary Shares  (GDTC) 
PDF SINGAPORE, Oct. 14, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical c [Read more]